Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/IIA Study of PET Imaging With 89Zr-Df-IAb2M in Patients With Metastatic Prostate Cancer

NCT01923727 is registered in ClinicalTrials.gov with ImaginAb, Inc. as lead sponsor.

NCT NCT01923727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01923727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/IIA Study of PET Imaging With 89Zr-Df-IAb2M in Patients With Metastatic Prostate Cancer
Lead sponsor
ImaginAb, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
August 31, 2013
Completion date
June 30, 2016
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic prostate cancer